This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | Last revision Both sides next revision | ||
dag3 [2022/05/13 09:22] trynke |
dag3 [2022/05/13 09:41] trynke |
||
---|---|---|---|
Line 16: | Line 16: | ||
* ~9000 participants were genotyped in the [[UGLI]] project. | * ~9000 participants were genotyped in the [[UGLI]] project. | ||
- | Metagenomic sequencing of the Lifelines DAG3 samples is underway to assess taxonomy, strain diversity and functionality. Uniquely, not only are all individuals fully genotyped but glycerol aliquots of their microbiota are also stored to enable bacterial culture for further functional studies. Lifelines DAG3 will have the power to study host-microbe interactions and will also allow studies to move from association to causality ((Doestzada, M., Vich Vila, A., Zhernakova, A., Koonen, D. P. Y., Weersma, R. K., Touw, D. J., ... Fu, J. | + | Metagenomic sequencing of the Lifelines DAG3 samples was performed to assess taxonomy, strain diversity and functionality. Uniquely, not only are all individuals fully genotyped but glycerol aliquots of their microbiota are also stored to enable bacterial culture for further functional studies. Lifelines DAG3 will have the power to study host-microbe interactions and will also allow studies to move from association to causality ((Doestzada, M., Vich Vila, A., Zhernakova, A., Koonen, D. P. Y., Weersma, R. K., Touw, D. J., ... Fu, J. |
(2018). Pharmacomicrobiomics: A novel route towards personalized medicine? Protein & cell, 9(5).)). | (2018). Pharmacomicrobiomics: A novel route towards personalized medicine? Protein & cell, 9(5).)). | ||